In modern cardiology, one of the greatest challenges is not treating heart attacks-but identifying silent coronary artery ...
6don MSN
Cardiologist explains why having a calcium score of zero does not make a person ‘heart attack proof’
Calcium score is a risk assessment tool and not a diagnostic test, as such, it cannot guarantee no chance of heart attack, explains Dr Yaranov.
HeartLung Corporation announced the publication of a new study in the American Journal of Preventive Cardiology titled “Comparing Incidence of Heart Failure in Individuals with Enlarged Cardiac ...
In patients with stable coronary artery disease, colchicine 0.5 mg per day did not impact low-attenuation plaque volume but ...
One of the biggest misconceptions is believing that “I work out regularly, so I must be healthy.” In reality, several hidden ...
US President Donald Trump underwent another medical examination at Walter Reed National Military Medical Center ahead of ...
As low-cost DEXA services expand across the longevity and medical weight loss market, Fitnescity Health establishes a quality framework to educate consumers and elevate the industry. Today, Fitnescity ...
Have you been diagnosed with hypertension, or dealing with fluctuating blood pressure? Read on to know the real facts about ...
Stop overpaying: Pay 30% less for higher quality medical imaging at Outpatient Radiology Scottsbluff
Content by Outpatient Radiology Scottsbluff. See how you can pay 30% less for higher quality medical imaging services at ...
Hosted on MSN
Soft vs. hard plaque in your arteries: Leading cardiologist explains which one is more dangerous
Soft and hard plaque are two different forms of fatty build-up inside your arteries, and both can quietly damage your heart over many years. The risk of heart attack becomes higher when soft plaque ...
Explore why whole-body scans attract investors while doctors warn against them due to overdiagnosis and lack of evidence.
MarketBeat on MSN
HeartFlow Q1 earnings call highlights
Heartflow (NASDAQ:HTFL) reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results